Signatope's Seed VC Round

Signatope raised a round of funding on May 24, 2017. Investors include High-Tech Grunderfonds.

Signatope develops protein assays that are capable of detecting and quantifying biomarkers for organ damage and drug interactions in blood, urine and tissue. In addition, Signatope offers analytical s…

Articles about Signatope's Seed VC Round: